Chinese biotechnology firm Rundo International has raised RMB100 million (US$14.85 million) in a series C round of financing from the country’s private equity firm Riverhead Capital, according to a statement released by the company on Monday.
This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of
